Posted in | News | Gold | Mining Business

Taku Acquires 100% Interest in McQ Gold Property in McQueston Gold District of Yukon

Taku Gold Corp. ("Taku") is pleased to announce that it has purchased a 100% interest in the McQ Gold property located in the emerging McQueston gold district of Yukon. As consideration, Taku will issue 100,000 shares to an arm's length vendor. Taku has also agreed to reimburse the vendor for all the McQ staking costs, estimated to be $24,000.

The McQ property comprises 96 contiguous claims (2,006 hectares), and is located approximately 35 kilometres northwest of Mayo, Yukon. The property lies roughly 30 kilometres southwest of Victoria Gold's Eagle Gold project which has stated National Instrument 43-101 compliant Probable Mineral Reserves of 91,600,000 tonnes grading 0.78 grams per tonne gold containing 2,300,768 ounces of gold (Victoria Gold Corp. - Technical Report, Eagle Gold Project, Yukon dated May 29, 2015). The property also adjoins the north boundary of Golden Predator's Gold Dome property where exploration drilling has intercepted significant gold mineralization at the Tom, Swede, Hawthorne, Harvey, and Aorta Zones (www.goldenpredator.com, consulted August 8, 2016).

"We are very pleased to have acquired the McQ property between Victoria Gold's shovel-ready Eagle Gold project and Golden Predator's well mineralized Gold Dome property," comments Zak Dingsdale, President and CEO of Taku.

Mark Fekete, P.Geo is the designated "qualified person" as defined in Section 1.2 in and for the purposes of National Instrument 43-101 that reviewed and approved the technical content of this release.

On Behalf of the Board of Taku Gold Corp.,

Zachery Dingsdale, CEO and President

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.